Evidence map›Paper›PMID 34699958›Full record

ArticleAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2022

Patient Preferences for Longer or More Frequent In-Center Hemodialysis Regimens: A Multicenter Discrete Choice Study.

James Fotheringham, Enric Vilar, Tarun Bansal, Paul Laboi, Andrew Davenport, Louese Dunn, Arne Risa Hole

Abstract readMulticenter Study
In one paragraph

Article in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. SAGE open medicine · 2026
    Article
  3. Article
  4. Exploring Healthcare Paradoxes in Hospital Haemodialysis-A Qualitative Study.Health expectations : an international journal of public participation in health care and health policy · 2024
    Article
  5. Effects ofClinical kidney journal · 2024
    Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

James FotheringhamSchool of Health and Related Research, University of Sheffield, Sheffield, United Kingdom; Sheffield Kidney Institute, Northern General Hospital, Sheffield, United Kingdom. Electronic address: j.fotheringham@sheffield.ac.uk.
Enric VilarUniversity of Hertfordshire, Hatfield, United Kingdom.
Tarun BansalBradford Teaching Hospitals NHS Trust, Bradford, United Kingdom.
Paul LaboiYork Teaching Hospital NHS Foundation Trust, York, United Kingdom.
Andrew DavenportUCL Department of Nephrology, Royal Free Hospital, University College London, London, United Kingdom.
Louese DunnSheffield Kidney Institute, Northern General Hospital, Sheffield, United Kingdom.
Arne Risa HoleDepartment of Economics, University of Sheffield, Sheffield, United Kingdom.

Funding

Department of Health
6 · The paper itself

Abstract

RATIONALE &

objectiveLonger and more frequent hemodialysis sessions are associated with both benefits and harms. However, their relative importance to patients and how they influence acceptability for patients have not been quantified. STUDY

designDiscrete-choice experiment in which a scenario followed by 12 treatment choice sets were presented to patients in conjunction with varying information about the clinical impact of the treatments offered. SETTING &

participantsPatients with kidney failure treated with maintenance dialysis for≥1 year in 5 UK kidney centers. PREDICTORS: Length and frequency of hemodialysis sessions and their prior reported associations with survival, quality of life, need for fluid restriction, hospitalization, and vascular access complications. OUTCOME: Selection of longer (4.5 hours) or more frequent (4 sessions per week) hemodialysis regimens versus remaining on 3 sessions per week with session lengths of 4 hours. ANALYTICAL APPROACH: Multinomial mixed effects logistic regression estimating the relative influence of different levels of the predictors on the selection of longer and more frequent dialysis, controlling for patient demographic characteristics.

resultsAmong 183 prevalent in-center hemodialysis patients (mean age of 63.7 years, mean dialysis vintage of 4.7 years), 38.3% (70 of 183) always chose to remain on regimens of 3 sessions per week with session duration of 4 hours. Depicted associations of increasing survival and quality of life, reduced need for fluid restriction, and avoiding additional access complications were all significantly associated with choosing longer or more frequent treatment regimens. Younger age, fatigue, previous experience of vascular access complications, absence of heart failure, and shorter travel time to dialysis centers were associated with preference for 4 sessions per week. Patients expressed willingness to trade up to 2 years of life to avoid regimens of 4 sessions per week or access complications. After applying estimated treatment benefits and harms from existing literature, the fully adjusted model revealed that 27.1% would choose longer regimens delivered 3 times per week and 34.3% would choose 4 hours 4 times per week. Analogous estimates for younger fatigued patients living near their unit were 23.5% and 62.5%, respectively. LIMITATIONS: Estimates were based on stated preferences rather than observed behaviors. Predicted acceptance of regimens was derived from data on treatment benefits and harms largely sourced from observational studies.

conclusionsPredicted acceptance of longer and more frequent hemodialysis regimens substantially exceeds their use in current clinical practice. These findings underscore the need for robust data on clinical effectiveness of these more intensive regimens and more extensive consideration of patient choice in the selection of dialysis regimens.

Indexed as

Kidney Failure, ChronicRenal InsufficiencyHumansMiddle AgedPatient PreferenceQuality of LifeRenal DialysisDialysis regimendiscrete choice experiment (DCE)end-stage renal disease (ESRD)frequent dialysisgoals of carehealth economicsintensive dialysislonger dialysispatient-centered carepatient preferencequality of life (QoL)shared decision makingtreatment burden

Identifiers

PMID34699958
PMCPMC9153730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.